|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$21,926,350 |
|
|
Indirect Value
|
$61,758 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$21,988,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-22 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
51,002 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-22 |
4 |
AS |
$159.00 |
$675,750 |
D/D |
(4,250) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
OE |
$86.52 |
$330,578 |
D/D |
3,708 |
50,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
AS |
$169.00 |
$626,652 |
D/D |
(3,708) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-13 |
4 |
OE |
$131.89 |
$840,799 |
D/D |
6,375 |
53,127 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-13 |
4 |
AS |
$179.00 |
$1,141,125 |
D/D |
(6,375) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-16 |
4 |
AS |
$179.85 |
$382,181 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-16 |
4 |
OE |
$96.87 |
$205,849 |
D/D |
2,125 |
48,877 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-02 |
4 |
OE |
$91.05 |
$476,479 |
D/D |
4,280 |
48,907 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-02 |
4 |
AS |
$174.59 |
$756,616 |
D/D |
(4,280) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-03 |
4 |
OE |
$86.52 |
$598,211 |
D/D |
5,803 |
52,555 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-03 |
4 |
AS |
$174.20 |
$1,010,883 |
D/D |
(5,803) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-05 |
4 |
OE |
$86.52 |
$598,211 |
D/D |
5,803 |
48,305 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-05 |
4 |
AS |
$172.08 |
$998,580 |
D/D |
(5,803) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-07 |
4 |
AS |
$179.00 |
$380,375 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-07 |
4 |
OE |
$131.89 |
$280,266 |
D/D |
2,125 |
48,877 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-15 |
4 |
AS |
$163.75 |
$4,749 |
D/D |
(29) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-01-22 |
4 |
OE |
$131.89 |
$280,266 |
D/D |
2,125 |
48,877 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-01-22 |
4 |
AS |
$193.48 |
$411,145 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-04 |
4 |
AS |
$184.81 |
$3,409,082 |
D/D |
(18,309) |
36,402 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-04 |
4 |
OE |
$86.52 |
$795,657 |
D/D |
7,959 |
54,711 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,535 |
71,937 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-11 |
4 |
AS |
$179.44 |
$5,959,969 |
D/D |
(33,073) |
38,864 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-04-15 |
4 |
AS |
$180.95 |
$1,022,148 |
D/D |
(5,624) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-05-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
35,395 |
0 |
- |
|
192 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|